Navigation Links
Beaumont Hospital Launches Study of Single-Dose Radiation Treatment for Prostate Cancer
Date:12/16/2010

ROYAL OAK, Mich., Dec. 16, 2010 /PRNewswire/ -- Beaumont Hospital radiation oncologists have launched a research study to treat men with low to intermediate risk prostate cancer with a single dose of radiation.

Alvaro Martinez, M.D., FACR, professor and chair, Oakland University William Beaumont School of Medicine, department of Radiation Oncology, Beaumont Hospitals, performed the first-in-the-world one-dose, High-Dose Rate brachytherapy procedure Nov. 29 on a man from Beverly Hills, Mich.

The study, approved by Beaumont's Human Investigation Committee, builds upon 18 years of past research by Dr. Martinez and other Beaumont radiation oncologists on ways to kill cancer cells through powerful, targeted, short-term radiation treatment.

"In the future of cancer care, less is more," says Dr. Martinez. "Patients want treatments that are safe, effective and fast with a high chance of a cure, thus allowing them to move on with their lives as soon as possible. Through our research, we are hoping to develop treatments that achieve these goals for patients."

HDR brachytherapy involves the temporary implantation of a "smart seed" – an Iridium 192 radioactive pellet about the size of grain of rice – at the prostate tumor site. This technique delivers more radiation to the prostate, increasing cancer killing probability, while minimizing radiation exposure to surrounding tissues, such as the bladder, urethra and rectum. Unlike permanent radioactive seed implants, no radioactive material is left in the patient's body, eliminating the risk of radiation exposure for partners or family members.

The entire procedure to temporarily implant the seed takes about three hours, once spinal anesthesia has been administered. Plastic needles are placed into the prostate using ultrasound guidance. The needles are then loaded with a single radiation seed through a cable attached to a computerized machine that moves the "smart seed" at precisely timed intervals along the needles. Treatment with the "smart seeds" takes about 15 minutes.

Low and intermediate risk patients who qualify for study participation include those with T1c through T2b tumors (small size with no metastasis or lymph node involvement), a Gleason score of 6 or 7 (low-intermediate cell aggressiveness) and a prostate-specific antigen score lower than 15.

For more information on the study or a consultation, call 248-551-7058 (for Beaumont Hospital, Royal Oak) or 248-964-3070 (for Beaumont Hospital, Troy).

Current methods for treating prostate cancer confined to the prostate gland include surgical removal of the prostate (radical prostatectomy); up to eight weeks of external beam radiation alone or combined with permanent seed implants or HDR brachytherapy; or permanent seed implants and/or HDR brachytherapy. The methods are about equal in effectiveness with different side effects.

In 1992, Dr. Martinez and his Beaumont colleagues were the first in the U.S. to perform HDR brachytherapy as an outpatient treatment for patients with locally-advanced prostate cancer. In 1995, he developed a four-treatment protocol over two days for patients with low to intermediate risk prostate cancer. A total of 1,045 patients with high, intermediate or low-risk prostate cancer have been treated through HDR brachytherapy research at Beaumont since 1992.

Beaumont's comprehensive cancer program combines the expertise of Beaumont Hospitals with the knowledge and experience of physicians in the Beaumont Oncology Network, the largest group of oncology specialists in the state, to offer cancer prevention counseling, diagnosis and treatment in hospital and community-based settings. The Beaumont Cancer Institute is one of only 47 Community Clinical Oncology Programs in the country designated by the National Cancer Institute to provide patients with access to leading-edge cancer clinical research trials.

HIC study 2006-038

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Alvaro Martinez, M.D.   |   https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=43100


'/>"/>
SOURCE William Beaumont Hospital
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Beaumont Hospital Opens New Ernst Cardiovascular Center
2. Beaumont Patients 1st to get Next Generation of Radiation Treatment
3. TeleTracking Presents Conference on RTLS Hospital Asset Tracking
4. Milliman Care Guidelines® Now Used in More Than 1,000 Hospitals
5. Med Time Technology, Inc. Teams up with Give A Smile, Inc. to Provide Pill Timer™ Kits and Toys to Children and Parents at the Chris Evert Childrens Hospital of Broward General
6. NeoStem Announces Agreement With Shijiazhuang Third Hospital in the Provincial Capital of Hebei Province, China to Offer Orthopedic Applications Based on NeoStem’s Licensed Technology
7. Reportlinker Adds Europe Hospital Supplies Market Outlook to 2016
8. CareFusion Launches Respiratory Airway Adapter to Improve Patient Safety and Reduce Hospital Costs
9. CareFusion to Provide Pyxis® Point-of-Care Products to Veterans Affairs Hospitals Nationwide
10. ECRI Institute PSO Chosen by Tennessee Hospital Association for Patient Safety Services
11. Analysis of Longer-Term Clinical Study Suggests Psychiatric Hospitalization Rates Decreased in Adults with Schizophrenia Treated With INVEGA® SUSTENNA®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... CLEVELAND , Jan. 19, 2017 ViewRay, ... (DFG), a federal institution supporting research in ... installation and patient treatments at the University Clinic Heidelberg ... The MRIdian Linac program will be headed ... who also heads radiation oncology at the German Cancer ...
(Date:1/19/2017)... CAMBRIDGE, England , January 19, 2017 ... MedImmune and Otsuka in the Milner Therapeutics Consortium   ... academic scientists in Cambridge   ... Inc. (NYSE: PFE ) as a partner ... join the Consortium, which enables the efficient transfer of ...
(Date:1/19/2017)... global  pacemaker market  is expected to reach USD 12.3 billion by 2025, according ... cardiac conditions coupled with the availability of medical coverage is a key driving ... devices are supporting the expansion of this vertical. ... ... Logo ...
Breaking Medicine Technology:
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... Lice Troopers, ... lice cases in families with school-aged children since the holiday season. , “It ... holidays with their families, sharing hugs and taking photos, which is the head-to-head gateway ...
(Date:1/20/2017)... ... January 20, 2017 , ... "TransFlare 4K Mystique comes ... of Final Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. ... Utilizing the Dragon Sensor,TransFlare 4K Mystique lens flare and light leak transitions have a ...
(Date:1/20/2017)... ... ... Biscuit”: a biographical account following a man who went on to support his country and ... born in Lynn Haven, Florida and at the age of 5, his family moved to ... joined the Navy and got married right out of boot camp. , He and ...
(Date:1/20/2017)... ... ... enchanting tale that teaches children the true meaning of Christmas. “Journey to Christmas” is the ... devoted woman of faith. , “Becoming a parent changes you. In my case, the ... years, but actually doing it might have been a while in coming if it hadn’t ...
(Date:1/19/2017)... ... 20, 2017 , ... Today, the Centers for Medicare & Medicaid Services (CMS) ... Payment Models (APMs) in 2017. Clinicians who participate in APMs are paid for the ... of the Administration’s effort to build a system that delivers better care and one ...
Breaking Medicine News(10 mins):